Form 4 · Filed Jun 5, 2026, 10:18 PM UTC
XERS/Xeris Biopharma Holdings, Inc.
HALKUFF DAWN — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | S | sell | 20,000 | $6 | $121,886 | 95,000 |
| Jun 4, 2026 | A | other | 24,193 | $0 | — | 119,193 |
| Jun 4, 2026 | A | other | 32,996 | — | — | 32,996 |
Source: SEC EDGAR raw filing ↗ · Accession 0001743658-26-000002